DCPlus raises on Base
Biotech‑on‑chain startup DCPlus raised $100k+ and launched staking for on‑chain products on Base, signaling more biotech builders choosing Layer‑2 rails (x.com). Community threads are using DCPlus as an example of early on‑chain capital formation and tokenized R&D experiments (x.com).
DCPlus completed its curated launch on Origo Hub (the DeSci launchpad on Base) on October 17, 2025. (crypto-reporter.com) Whitepaper and launch materials set DCPLUS total supply at 1,000,000,000 tokens and allocate 2% of that supply — 20,000,000 DCPLUS — to a staking‑reward pool. (crypto-reporter.com) Origo’s ecosystem documentation says the launch was supported with more than $200,000 in liquidity and ecosystem backing routed through Origo programs. (origolabs.io) The DCPLUS token contract on Base is 0x10B2cF5A47e9DEA699bd7aCCc88AbBAE269f28f9, and on‑chain DEX data shows an active Uniswap V2 pool with roughly $540k–$550k in pooled liquidity and daily volumes in the ~$50k–$60k range. (geckoterminal.com) Aggregators and exchange trackers report a live market capitalization in the vicinity of $1.7 million and continue to show the 1,000,000,000 max supply figure published at launch. (web3.okx.com) Project press releases link DCPlus’s token utility to a patented transdermal gas therapy patch developed with Taiwan’s Medical Gas Research Center and cite clinical validation for wound‑healing and tissue‑regeneration use cases. (crypto-reporter.com) Multiple niche crypto outlets and DeSci commentators have flagged DCPlus as an early “DeSci + RWA” experiment on Base, noting the tokenized R&D narrative and the staged liquidity/staking mechanics that accompanied the launch. (coinfomania.com)
